When progress stalls, we look for ways to break through by adjusting one or more areas: changes in diet, shifts in exercise routines, incorporating periods of fasting, modifying current medications, or adding a second medication to create a dual-therapy approach
It is not a GLP-1, not a weight-loss drug, and should not be treated as one
Weekly or bi-weekly, depending on individual needs
AOD-9604 and BPC-157 in Combination Research AOD-9604 and BPC-157 are frequently mentioned together in peptide research discussions because theyre studied in adjacent but distinct areas AOD-9604 in fat metabolism, BPC-157 in tissue repair and gastrointestinal research rather than because of any overlapping mechanism
Olympias compounded NAD+ may be administered via IV, IM, or SubQ routes, depending on your care plan